These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32479336)

  • 1. A meta-analysis of the potential antidepressant effects of buprenorphine versus placebo as an adjunctive pharmacotherapy for treatment-resistant depression.
    Dinoff A; Lynch ST; Sekhri N; Klepacz L
    J Affect Disord; 2020 Jun; 271():91-99. PubMed ID: 32479336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic and pharmacokinetic evaluation of buprenorphine + samidorphan for the treatment of major depressive disorder.
    Ragguett RM; Rong C; Rosenblat JD; Ho RC; McIntyre RS
    Expert Opin Drug Metab Toxicol; 2018 Apr; 14(4):475-482. PubMed ID: 29621905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review.
    Serafini G; Adavastro G; Canepa G; De Berardis D; Valchera A; Pompili M; Nasrallah H; Amore M
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30111745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.
    Fava M; Memisoglu A; Thase ME; Bodkin JA; Trivedi MH; de Somer M; Du Y; Leigh-Pemberton R; DiPetrillo L; Silverman B; Ehrich E
    Am J Psychiatry; 2016 May; 173(5):499-508. PubMed ID: 26869247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of buprenorphine in the treatment of drug-resistant depression - an overview of the studies.
    Stefanowski B; Antosik-Wójcińska A; Święcicki Ł
    Psychiatr Pol; 2020 Apr; 54(2):199-207. PubMed ID: 32772054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Buprenorphine in treatment of refractory depression-A review of current literature.
    Stanciu CN; Glass OM; Penders TM
    Asian J Psychiatr; 2017 Apr; 26():94-98. PubMed ID: 28483102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
    Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008324. PubMed ID: 23152255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine: prospective novel therapy for depression and PTSD.
    Madison CA; Eitan S
    Psychol Med; 2020 Apr; 50(6):881-893. PubMed ID: 32204739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults.
    Karp JF; Butters MA; Begley AE; Miller MD; Lenze EJ; Blumberger DM; Mulsant BH; Reynolds CF
    J Clin Psychiatry; 2014 Aug; 75(8):e785-93. PubMed ID: 25191915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression.
    Baumeister H; Hutter N; Bengel J
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008381. PubMed ID: 23235661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The integrative management of treatment-resistant depression: a comprehensive review and perspectives.
    Carvalho AF; Berk M; Hyphantis TN; McIntyre RS
    Psychother Psychosom; 2014; 83(2):70-88. PubMed ID: 24458008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
    Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C
    J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brexpiprazole as Adjunctive Treatment for Major Depressive Disorder Following Treatment Failure With at Least One Antidepressant in the Current Episode: a Systematic Review and Meta-Analysis.
    Kishi T; Sakuma K; Nomura I; Matsuda Y; Mishima K; Iwata N
    Int J Neuropsychopharmacol; 2019 Nov; 22(11):698-709. PubMed ID: 31350882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, quality of life, and acceptability outcomes of atypical antipsychotic augmentation treatment for treatment-resistant depression: protocol for a systematic review and network meta-analysis.
    Liu Y; Zhou X; Qin B; Del Giovane C; Zhang Y; Xie P
    Syst Rev; 2014 Nov; 3():133. PubMed ID: 25373601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial.
    Yang C; Bosker FJ; Li J; Schoevers RA
    BMC Psychiatry; 2018 Sep; 18(1):279. PubMed ID: 30176835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Salagre E; Fernandes BS; Dodd S; Brownstein DJ; Berk M
    J Affect Disord; 2016 Aug; 200():235-42. PubMed ID: 27148902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
    Daly EJ; Trivedi MH; Janik A; Li H; Zhang Y; Li X; Lane R; Lim P; Duca AR; Hough D; Thase ME; Zajecka J; Winokur A; Divacka I; Fagiolini A; Cubala WJ; Bitter I; Blier P; Shelton RC; Molero P; Manji H; Drevets WC; Singh JB
    JAMA Psychiatry; 2019 Sep; 76(9):893-903. PubMed ID: 31166571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of St. John's wort for major depressive disorder.
    Apaydin EA; Maher AR; Shanman R; Booth MS; Miles JN; Sorbero ME; Hempel S
    Syst Rev; 2016 Sep; 5(1):148. PubMed ID: 27589952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.